Global Autologous Cell Therapy Products Supply, Demand and Key Producers, 2023-2029
The global Autologous Cell Therapy Products market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Autologous cell therapy is a medical treatment approach that involves using a patient's own cells to treat a specific medical condition or promote healing. This type of therapy is personalized and based on the principle that cells from the patient's own body are less likely to trigger immune responses or rejection, making it a potentially effective and safe treatment option for various conditions.
This report studies the global Autologous Cell Therapy Products production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Autologous Cell Therapy Products, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Autologous Cell Therapy Products that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Autologous Cell Therapy Products total production and demand, 2018-2029, (K Units)
Global Autologous Cell Therapy Products total production value, 2018-2029, (USD Million)
Global Autologous Cell Therapy Products production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Autologous Cell Therapy Products consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Autologous Cell Therapy Products domestic production, consumption, key domestic manufacturers and share
Global Autologous Cell Therapy Products production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Autologous Cell Therapy Products production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Autologous Cell Therapy Products production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Autologous Cell Therapy Products market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, Johnson & Johnson, Autolus Therapeutics, FOSUNKite, JW Therapeutics, CARsgen Therapeutics and Sorrento Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Autologous Cell Therapy Products market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Autologous Cell Therapy Products Market, By Region:
1. How big is the global Autologous Cell Therapy Products market?
2. What is the demand of the global Autologous Cell Therapy Products market?
3. What is the year over year growth of the global Autologous Cell Therapy Products market?
4. What is the production and production value of the global Autologous Cell Therapy Products market?
5. Who are the key producers in the global Autologous Cell Therapy Products market?
6. What are the growth factors driving the market demand?
Autologous cell therapy is a medical treatment approach that involves using a patient's own cells to treat a specific medical condition or promote healing. This type of therapy is personalized and based on the principle that cells from the patient's own body are less likely to trigger immune responses or rejection, making it a potentially effective and safe treatment option for various conditions.
This report studies the global Autologous Cell Therapy Products production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Autologous Cell Therapy Products, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Autologous Cell Therapy Products that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Autologous Cell Therapy Products total production and demand, 2018-2029, (K Units)
Global Autologous Cell Therapy Products total production value, 2018-2029, (USD Million)
Global Autologous Cell Therapy Products production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Autologous Cell Therapy Products consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Autologous Cell Therapy Products domestic production, consumption, key domestic manufacturers and share
Global Autologous Cell Therapy Products production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Autologous Cell Therapy Products production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Autologous Cell Therapy Products production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Autologous Cell Therapy Products market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, Johnson & Johnson, Autolus Therapeutics, FOSUNKite, JW Therapeutics, CARsgen Therapeutics and Sorrento Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Autologous Cell Therapy Products market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Autologous Cell Therapy Products Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Autologous Stem Cell Transplants
- Autologous T Cell Therapies
- Platelet-Rich Plasma (PRP) Therapy
- Others
- Cancer
- Hemophilia
- Others
- Novartis
- Gilead Sciences
- Bristol-Myers Squibb
- Johnson & Johnson
- Autolus Therapeutics
- FOSUNKite
- JW Therapeutics
- CARsgen Therapeutics
- Sorrento Therapeutics
- Mustang Bio
- Cellectis
- Allogene Therapeutics
- Celyad Oncology
- Bluebird Bio
- Lonza
1. How big is the global Autologous Cell Therapy Products market?
2. What is the demand of the global Autologous Cell Therapy Products market?
3. What is the year over year growth of the global Autologous Cell Therapy Products market?
4. What is the production and production value of the global Autologous Cell Therapy Products market?
5. Who are the key producers in the global Autologous Cell Therapy Products market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Autologous Cell Therapy Products Introduction
1.2 World Autologous Cell Therapy Products Supply & Forecast
1.2.1 World Autologous Cell Therapy Products Production Value (2018 & 2022 & 2029)
1.2.2 World Autologous Cell Therapy Products Production (2018-2029)
1.2.3 World Autologous Cell Therapy Products Pricing Trends (2018-2029)
1.3 World Autologous Cell Therapy Products Production by Region (Based on Production Site)
1.3.1 World Autologous Cell Therapy Products Production Value by Region (2018-2029)
1.3.2 World Autologous Cell Therapy Products Production by Region (2018-2029)
1.3.3 World Autologous Cell Therapy Products Average Price by Region (2018-2029)
1.3.4 North America Autologous Cell Therapy Products Production (2018-2029)
1.3.5 Europe Autologous Cell Therapy Products Production (2018-2029)
1.3.6 China Autologous Cell Therapy Products Production (2018-2029)
1.3.7 Japan Autologous Cell Therapy Products Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Autologous Cell Therapy Products Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Autologous Cell Therapy Products Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Autologous Cell Therapy Products Demand (2018-2029)
2.2 World Autologous Cell Therapy Products Consumption by Region
2.2.1 World Autologous Cell Therapy Products Consumption by Region (2018-2023)
2.2.2 World Autologous Cell Therapy Products Consumption Forecast by Region (2024-2029)
2.3 United States Autologous Cell Therapy Products Consumption (2018-2029)
2.4 China Autologous Cell Therapy Products Consumption (2018-2029)
2.5 Europe Autologous Cell Therapy Products Consumption (2018-2029)
2.6 Japan Autologous Cell Therapy Products Consumption (2018-2029)
2.7 South Korea Autologous Cell Therapy Products Consumption (2018-2029)
2.8 ASEAN Autologous Cell Therapy Products Consumption (2018-2029)
2.9 India Autologous Cell Therapy Products Consumption (2018-2029)
3 WORLD AUTOLOGOUS CELL THERAPY PRODUCTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Autologous Cell Therapy Products Production Value by Manufacturer (2018-2023)
3.2 World Autologous Cell Therapy Products Production by Manufacturer (2018-2023)
3.3 World Autologous Cell Therapy Products Average Price by Manufacturer (2018-2023)
3.4 Autologous Cell Therapy Products Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Autologous Cell Therapy Products Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Autologous Cell Therapy Products in 2022
3.5.3 Global Concentration Ratios (CR8) for Autologous Cell Therapy Products in 2022
3.6 Autologous Cell Therapy Products Market: Overall Company Footprint Analysis
3.6.1 Autologous Cell Therapy Products Market: Region Footprint
3.6.2 Autologous Cell Therapy Products Market: Company Product Type Footprint
3.6.3 Autologous Cell Therapy Products Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Autologous Cell Therapy Products Production Value Comparison
4.1.1 United States VS China: Autologous Cell Therapy Products Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Autologous Cell Therapy Products Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Autologous Cell Therapy Products Production Comparison
4.2.1 United States VS China: Autologous Cell Therapy Products Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Autologous Cell Therapy Products Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Autologous Cell Therapy Products Consumption Comparison
4.3.1 United States VS China: Autologous Cell Therapy Products Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Autologous Cell Therapy Products Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Autologous Cell Therapy Products Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Autologous Cell Therapy Products Production Value (2018-2023)
4.4.3 United States Based Manufacturers Autologous Cell Therapy Products Production (2018-2023)
4.5 China Based Autologous Cell Therapy Products Manufacturers and Market Share
4.5.1 China Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Autologous Cell Therapy Products Production Value (2018-2023)
4.5.3 China Based Manufacturers Autologous Cell Therapy Products Production (2018-2023)
4.6 Rest of World Based Autologous Cell Therapy Products Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Autologous Cell Therapy Products Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Autologous Cell Therapy Products Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Autologous Cell Therapy Products Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Autologous Stem Cell Transplants
5.2.2 Autologous T Cell Therapies
5.2.3 Platelet-Rich Plasma (PRP) Therapy
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Autologous Cell Therapy Products Production by Type (2018-2029)
5.3.2 World Autologous Cell Therapy Products Production Value by Type (2018-2029)
5.3.3 World Autologous Cell Therapy Products Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Autologous Cell Therapy Products Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Hemophilia
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Autologous Cell Therapy Products Production by Application (2018-2029)
6.3.2 World Autologous Cell Therapy Products Production Value by Application (2018-2029)
6.3.3 World Autologous Cell Therapy Products Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Autologous Cell Therapy Products Product and Services
7.1.4 Novartis Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Gilead Sciences
7.2.1 Gilead Sciences Details
7.2.2 Gilead Sciences Major Business
7.2.3 Gilead Sciences Autologous Cell Therapy Products Product and Services
7.2.4 Gilead Sciences Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Gilead Sciences Recent Developments/Updates
7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Details
7.3.2 Bristol-Myers Squibb Major Business
7.3.3 Bristol-Myers Squibb Autologous Cell Therapy Products Product and Services
7.3.4 Bristol-Myers Squibb Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bristol-Myers Squibb Recent Developments/Updates
7.3.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Details
7.4.2 Johnson & Johnson Major Business
7.4.3 Johnson & Johnson Autologous Cell Therapy Products Product and Services
7.4.4 Johnson & Johnson Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Johnson & Johnson Recent Developments/Updates
7.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.5 Autolus Therapeutics
7.5.1 Autolus Therapeutics Details
7.5.2 Autolus Therapeutics Major Business
7.5.3 Autolus Therapeutics Autologous Cell Therapy Products Product and Services
7.5.4 Autolus Therapeutics Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Autolus Therapeutics Recent Developments/Updates
7.5.6 Autolus Therapeutics Competitive Strengths & Weaknesses
7.6 FOSUNKite
7.6.1 FOSUNKite Details
7.6.2 FOSUNKite Major Business
7.6.3 FOSUNKite Autologous Cell Therapy Products Product and Services
7.6.4 FOSUNKite Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 FOSUNKite Recent Developments/Updates
7.6.6 FOSUNKite Competitive Strengths & Weaknesses
7.7 JW Therapeutics
7.7.1 JW Therapeutics Details
7.7.2 JW Therapeutics Major Business
7.7.3 JW Therapeutics Autologous Cell Therapy Products Product and Services
7.7.4 JW Therapeutics Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 JW Therapeutics Recent Developments/Updates
7.7.6 JW Therapeutics Competitive Strengths & Weaknesses
7.8 CARsgen Therapeutics
7.8.1 CARsgen Therapeutics Details
7.8.2 CARsgen Therapeutics Major Business
7.8.3 CARsgen Therapeutics Autologous Cell Therapy Products Product and Services
7.8.4 CARsgen Therapeutics Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 CARsgen Therapeutics Recent Developments/Updates
7.8.6 CARsgen Therapeutics Competitive Strengths & Weaknesses
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Details
7.9.2 Sorrento Therapeutics Major Business
7.9.3 Sorrento Therapeutics Autologous Cell Therapy Products Product and Services
7.9.4 Sorrento Therapeutics Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Sorrento Therapeutics Recent Developments/Updates
7.9.6 Sorrento Therapeutics Competitive Strengths & Weaknesses
7.10 Mustang Bio
7.10.1 Mustang Bio Details
7.10.2 Mustang Bio Major Business
7.10.3 Mustang Bio Autologous Cell Therapy Products Product and Services
7.10.4 Mustang Bio Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Mustang Bio Recent Developments/Updates
7.10.6 Mustang Bio Competitive Strengths & Weaknesses
7.11 Cellectis
7.11.1 Cellectis Details
7.11.2 Cellectis Major Business
7.11.3 Cellectis Autologous Cell Therapy Products Product and Services
7.11.4 Cellectis Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Cellectis Recent Developments/Updates
7.11.6 Cellectis Competitive Strengths & Weaknesses
7.12 Allogene Therapeutics
7.12.1 Allogene Therapeutics Details
7.12.2 Allogene Therapeutics Major Business
7.12.3 Allogene Therapeutics Autologous Cell Therapy Products Product and Services
7.12.4 Allogene Therapeutics Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Allogene Therapeutics Recent Developments/Updates
7.12.6 Allogene Therapeutics Competitive Strengths & Weaknesses
7.13 Celyad Oncology
7.13.1 Celyad Oncology Details
7.13.2 Celyad Oncology Major Business
7.13.3 Celyad Oncology Autologous Cell Therapy Products Product and Services
7.13.4 Celyad Oncology Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Celyad Oncology Recent Developments/Updates
7.13.6 Celyad Oncology Competitive Strengths & Weaknesses
7.14 Bluebird Bio
7.14.1 Bluebird Bio Details
7.14.2 Bluebird Bio Major Business
7.14.3 Bluebird Bio Autologous Cell Therapy Products Product and Services
7.14.4 Bluebird Bio Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bluebird Bio Recent Developments/Updates
7.14.6 Bluebird Bio Competitive Strengths & Weaknesses
7.15 Lonza
7.15.1 Lonza Details
7.15.2 Lonza Major Business
7.15.3 Lonza Autologous Cell Therapy Products Product and Services
7.15.4 Lonza Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Lonza Recent Developments/Updates
7.15.6 Lonza Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Autologous Cell Therapy Products Industry Chain
8.2 Autologous Cell Therapy Products Upstream Analysis
8.2.1 Autologous Cell Therapy Products Core Raw Materials
8.2.2 Main Manufacturers of Autologous Cell Therapy Products Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Autologous Cell Therapy Products Production Mode
8.6 Autologous Cell Therapy Products Procurement Model
8.7 Autologous Cell Therapy Products Industry Sales Model and Sales Channels
8.7.1 Autologous Cell Therapy Products Sales Model
8.7.2 Autologous Cell Therapy Products Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Autologous Cell Therapy Products Introduction
1.2 World Autologous Cell Therapy Products Supply & Forecast
1.2.1 World Autologous Cell Therapy Products Production Value (2018 & 2022 & 2029)
1.2.2 World Autologous Cell Therapy Products Production (2018-2029)
1.2.3 World Autologous Cell Therapy Products Pricing Trends (2018-2029)
1.3 World Autologous Cell Therapy Products Production by Region (Based on Production Site)
1.3.1 World Autologous Cell Therapy Products Production Value by Region (2018-2029)
1.3.2 World Autologous Cell Therapy Products Production by Region (2018-2029)
1.3.3 World Autologous Cell Therapy Products Average Price by Region (2018-2029)
1.3.4 North America Autologous Cell Therapy Products Production (2018-2029)
1.3.5 Europe Autologous Cell Therapy Products Production (2018-2029)
1.3.6 China Autologous Cell Therapy Products Production (2018-2029)
1.3.7 Japan Autologous Cell Therapy Products Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Autologous Cell Therapy Products Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Autologous Cell Therapy Products Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Autologous Cell Therapy Products Demand (2018-2029)
2.2 World Autologous Cell Therapy Products Consumption by Region
2.2.1 World Autologous Cell Therapy Products Consumption by Region (2018-2023)
2.2.2 World Autologous Cell Therapy Products Consumption Forecast by Region (2024-2029)
2.3 United States Autologous Cell Therapy Products Consumption (2018-2029)
2.4 China Autologous Cell Therapy Products Consumption (2018-2029)
2.5 Europe Autologous Cell Therapy Products Consumption (2018-2029)
2.6 Japan Autologous Cell Therapy Products Consumption (2018-2029)
2.7 South Korea Autologous Cell Therapy Products Consumption (2018-2029)
2.8 ASEAN Autologous Cell Therapy Products Consumption (2018-2029)
2.9 India Autologous Cell Therapy Products Consumption (2018-2029)
3 WORLD AUTOLOGOUS CELL THERAPY PRODUCTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Autologous Cell Therapy Products Production Value by Manufacturer (2018-2023)
3.2 World Autologous Cell Therapy Products Production by Manufacturer (2018-2023)
3.3 World Autologous Cell Therapy Products Average Price by Manufacturer (2018-2023)
3.4 Autologous Cell Therapy Products Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Autologous Cell Therapy Products Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Autologous Cell Therapy Products in 2022
3.5.3 Global Concentration Ratios (CR8) for Autologous Cell Therapy Products in 2022
3.6 Autologous Cell Therapy Products Market: Overall Company Footprint Analysis
3.6.1 Autologous Cell Therapy Products Market: Region Footprint
3.6.2 Autologous Cell Therapy Products Market: Company Product Type Footprint
3.6.3 Autologous Cell Therapy Products Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Autologous Cell Therapy Products Production Value Comparison
4.1.1 United States VS China: Autologous Cell Therapy Products Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Autologous Cell Therapy Products Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Autologous Cell Therapy Products Production Comparison
4.2.1 United States VS China: Autologous Cell Therapy Products Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Autologous Cell Therapy Products Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Autologous Cell Therapy Products Consumption Comparison
4.3.1 United States VS China: Autologous Cell Therapy Products Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Autologous Cell Therapy Products Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Autologous Cell Therapy Products Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Autologous Cell Therapy Products Production Value (2018-2023)
4.4.3 United States Based Manufacturers Autologous Cell Therapy Products Production (2018-2023)
4.5 China Based Autologous Cell Therapy Products Manufacturers and Market Share
4.5.1 China Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Autologous Cell Therapy Products Production Value (2018-2023)
4.5.3 China Based Manufacturers Autologous Cell Therapy Products Production (2018-2023)
4.6 Rest of World Based Autologous Cell Therapy Products Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Autologous Cell Therapy Products Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Autologous Cell Therapy Products Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Autologous Cell Therapy Products Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Autologous Stem Cell Transplants
5.2.2 Autologous T Cell Therapies
5.2.3 Platelet-Rich Plasma (PRP) Therapy
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Autologous Cell Therapy Products Production by Type (2018-2029)
5.3.2 World Autologous Cell Therapy Products Production Value by Type (2018-2029)
5.3.3 World Autologous Cell Therapy Products Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Autologous Cell Therapy Products Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Hemophilia
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Autologous Cell Therapy Products Production by Application (2018-2029)
6.3.2 World Autologous Cell Therapy Products Production Value by Application (2018-2029)
6.3.3 World Autologous Cell Therapy Products Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Autologous Cell Therapy Products Product and Services
7.1.4 Novartis Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Gilead Sciences
7.2.1 Gilead Sciences Details
7.2.2 Gilead Sciences Major Business
7.2.3 Gilead Sciences Autologous Cell Therapy Products Product and Services
7.2.4 Gilead Sciences Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Gilead Sciences Recent Developments/Updates
7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Details
7.3.2 Bristol-Myers Squibb Major Business
7.3.3 Bristol-Myers Squibb Autologous Cell Therapy Products Product and Services
7.3.4 Bristol-Myers Squibb Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bristol-Myers Squibb Recent Developments/Updates
7.3.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Details
7.4.2 Johnson & Johnson Major Business
7.4.3 Johnson & Johnson Autologous Cell Therapy Products Product and Services
7.4.4 Johnson & Johnson Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Johnson & Johnson Recent Developments/Updates
7.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.5 Autolus Therapeutics
7.5.1 Autolus Therapeutics Details
7.5.2 Autolus Therapeutics Major Business
7.5.3 Autolus Therapeutics Autologous Cell Therapy Products Product and Services
7.5.4 Autolus Therapeutics Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Autolus Therapeutics Recent Developments/Updates
7.5.6 Autolus Therapeutics Competitive Strengths & Weaknesses
7.6 FOSUNKite
7.6.1 FOSUNKite Details
7.6.2 FOSUNKite Major Business
7.6.3 FOSUNKite Autologous Cell Therapy Products Product and Services
7.6.4 FOSUNKite Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 FOSUNKite Recent Developments/Updates
7.6.6 FOSUNKite Competitive Strengths & Weaknesses
7.7 JW Therapeutics
7.7.1 JW Therapeutics Details
7.7.2 JW Therapeutics Major Business
7.7.3 JW Therapeutics Autologous Cell Therapy Products Product and Services
7.7.4 JW Therapeutics Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 JW Therapeutics Recent Developments/Updates
7.7.6 JW Therapeutics Competitive Strengths & Weaknesses
7.8 CARsgen Therapeutics
7.8.1 CARsgen Therapeutics Details
7.8.2 CARsgen Therapeutics Major Business
7.8.3 CARsgen Therapeutics Autologous Cell Therapy Products Product and Services
7.8.4 CARsgen Therapeutics Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 CARsgen Therapeutics Recent Developments/Updates
7.8.6 CARsgen Therapeutics Competitive Strengths & Weaknesses
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Details
7.9.2 Sorrento Therapeutics Major Business
7.9.3 Sorrento Therapeutics Autologous Cell Therapy Products Product and Services
7.9.4 Sorrento Therapeutics Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Sorrento Therapeutics Recent Developments/Updates
7.9.6 Sorrento Therapeutics Competitive Strengths & Weaknesses
7.10 Mustang Bio
7.10.1 Mustang Bio Details
7.10.2 Mustang Bio Major Business
7.10.3 Mustang Bio Autologous Cell Therapy Products Product and Services
7.10.4 Mustang Bio Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Mustang Bio Recent Developments/Updates
7.10.6 Mustang Bio Competitive Strengths & Weaknesses
7.11 Cellectis
7.11.1 Cellectis Details
7.11.2 Cellectis Major Business
7.11.3 Cellectis Autologous Cell Therapy Products Product and Services
7.11.4 Cellectis Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Cellectis Recent Developments/Updates
7.11.6 Cellectis Competitive Strengths & Weaknesses
7.12 Allogene Therapeutics
7.12.1 Allogene Therapeutics Details
7.12.2 Allogene Therapeutics Major Business
7.12.3 Allogene Therapeutics Autologous Cell Therapy Products Product and Services
7.12.4 Allogene Therapeutics Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Allogene Therapeutics Recent Developments/Updates
7.12.6 Allogene Therapeutics Competitive Strengths & Weaknesses
7.13 Celyad Oncology
7.13.1 Celyad Oncology Details
7.13.2 Celyad Oncology Major Business
7.13.3 Celyad Oncology Autologous Cell Therapy Products Product and Services
7.13.4 Celyad Oncology Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Celyad Oncology Recent Developments/Updates
7.13.6 Celyad Oncology Competitive Strengths & Weaknesses
7.14 Bluebird Bio
7.14.1 Bluebird Bio Details
7.14.2 Bluebird Bio Major Business
7.14.3 Bluebird Bio Autologous Cell Therapy Products Product and Services
7.14.4 Bluebird Bio Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bluebird Bio Recent Developments/Updates
7.14.6 Bluebird Bio Competitive Strengths & Weaknesses
7.15 Lonza
7.15.1 Lonza Details
7.15.2 Lonza Major Business
7.15.3 Lonza Autologous Cell Therapy Products Product and Services
7.15.4 Lonza Autologous Cell Therapy Products Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Lonza Recent Developments/Updates
7.15.6 Lonza Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Autologous Cell Therapy Products Industry Chain
8.2 Autologous Cell Therapy Products Upstream Analysis
8.2.1 Autologous Cell Therapy Products Core Raw Materials
8.2.2 Main Manufacturers of Autologous Cell Therapy Products Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Autologous Cell Therapy Products Production Mode
8.6 Autologous Cell Therapy Products Procurement Model
8.7 Autologous Cell Therapy Products Industry Sales Model and Sales Channels
8.7.1 Autologous Cell Therapy Products Sales Model
8.7.2 Autologous Cell Therapy Products Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Autologous Cell Therapy Products Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Autologous Cell Therapy Products Production Value by Region (2018-2023) & (USD Million)
Table 3. World Autologous Cell Therapy Products Production Value by Region (2024-2029) & (USD Million)
Table 4. World Autologous Cell Therapy Products Production Value Market Share by Region (2018-2023)
Table 5. World Autologous Cell Therapy Products Production Value Market Share by Region (2024-2029)
Table 6. World Autologous Cell Therapy Products Production by Region (2018-2023) & (K Units)
Table 7. World Autologous Cell Therapy Products Production by Region (2024-2029) & (K Units)
Table 8. World Autologous Cell Therapy Products Production Market Share by Region (2018-2023)
Table 9. World Autologous Cell Therapy Products Production Market Share by Region (2024-2029)
Table 10. World Autologous Cell Therapy Products Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Autologous Cell Therapy Products Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Autologous Cell Therapy Products Major Market Trends
Table 13. World Autologous Cell Therapy Products Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Autologous Cell Therapy Products Consumption by Region (2018-2023) & (K Units)
Table 15. World Autologous Cell Therapy Products Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Autologous Cell Therapy Products Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Autologous Cell Therapy Products Producers in 2022
Table 18. World Autologous Cell Therapy Products Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Autologous Cell Therapy Products Producers in 2022
Table 20. World Autologous Cell Therapy Products Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Autologous Cell Therapy Products Company Evaluation Quadrant
Table 22. World Autologous Cell Therapy Products Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Autologous Cell Therapy Products Production Site of Key Manufacturer
Table 24. Autologous Cell Therapy Products Market: Company Product Type Footprint
Table 25. Autologous Cell Therapy Products Market: Company Product Application Footprint
Table 26. Autologous Cell Therapy Products Competitive Factors
Table 27. Autologous Cell Therapy Products New Entrant and Capacity Expansion Plans
Table 28. Autologous Cell Therapy Products Mergers & Acquisitions Activity
Table 29. United States VS China Autologous Cell Therapy Products Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Autologous Cell Therapy Products Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Autologous Cell Therapy Products Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Autologous Cell Therapy Products Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Autologous Cell Therapy Products Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Autologous Cell Therapy Products Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Autologous Cell Therapy Products Production Market Share (2018-2023)
Table 37. China Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Autologous Cell Therapy Products Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Autologous Cell Therapy Products Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Autologous Cell Therapy Products Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Autologous Cell Therapy Products Production Market Share (2018-2023)
Table 42. Rest of World Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Autologous Cell Therapy Products Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Autologous Cell Therapy Products Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Autologous Cell Therapy Products Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Autologous Cell Therapy Products Production Market Share (2018-2023)
Table 47. World Autologous Cell Therapy Products Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Autologous Cell Therapy Products Production by Type (2018-2023) & (K Units)
Table 49. World Autologous Cell Therapy Products Production by Type (2024-2029) & (K Units)
Table 50. World Autologous Cell Therapy Products Production Value by Type (2018-2023) & (USD Million)
Table 51. World Autologous Cell Therapy Products Production Value by Type (2024-2029) & (USD Million)
Table 52. World Autologous Cell Therapy Products Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Autologous Cell Therapy Products Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Autologous Cell Therapy Products Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Autologous Cell Therapy Products Production by Application (2018-2023) & (K Units)
Table 56. World Autologous Cell Therapy Products Production by Application (2024-2029) & (K Units)
Table 57. World Autologous Cell Therapy Products Production Value by Application (2018-2023) & (USD Million)
Table 58. World Autologous Cell Therapy Products Production Value by Application (2024-2029) & (USD Million)
Table 59. World Autologous Cell Therapy Products Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Autologous Cell Therapy Products Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Autologous Cell Therapy Products Product and Services
Table 64. Novartis Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 68. Gilead Sciences Major Business
Table 69. Gilead Sciences Autologous Cell Therapy Products Product and Services
Table 70. Gilead Sciences Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Gilead Sciences Recent Developments/Updates
Table 72. Gilead Sciences Competitive Strengths & Weaknesses
Table 73. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 74. Bristol-Myers Squibb Major Business
Table 75. Bristol-Myers Squibb Autologous Cell Therapy Products Product and Services
Table 76. Bristol-Myers Squibb Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bristol-Myers Squibb Recent Developments/Updates
Table 78. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 79. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 80. Johnson & Johnson Major Business
Table 81. Johnson & Johnson Autologous Cell Therapy Products Product and Services
Table 82. Johnson & Johnson Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Johnson & Johnson Recent Developments/Updates
Table 84. Johnson & Johnson Competitive Strengths & Weaknesses
Table 85. Autolus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Autolus Therapeutics Major Business
Table 87. Autolus Therapeutics Autologous Cell Therapy Products Product and Services
Table 88. Autolus Therapeutics Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Autolus Therapeutics Recent Developments/Updates
Table 90. Autolus Therapeutics Competitive Strengths & Weaknesses
Table 91. FOSUNKite Basic Information, Manufacturing Base and Competitors
Table 92. FOSUNKite Major Business
Table 93. FOSUNKite Autologous Cell Therapy Products Product and Services
Table 94. FOSUNKite Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. FOSUNKite Recent Developments/Updates
Table 96. FOSUNKite Competitive Strengths & Weaknesses
Table 97. JW Therapeutics Basic Information, Manufacturing Base and Competitors
Table 98. JW Therapeutics Major Business
Table 99. JW Therapeutics Autologous Cell Therapy Products Product and Services
Table 100. JW Therapeutics Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. JW Therapeutics Recent Developments/Updates
Table 102. JW Therapeutics Competitive Strengths & Weaknesses
Table 103. CARsgen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 104. CARsgen Therapeutics Major Business
Table 105. CARsgen Therapeutics Autologous Cell Therapy Products Product and Services
Table 106. CARsgen Therapeutics Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. CARsgen Therapeutics Recent Developments/Updates
Table 108. CARsgen Therapeutics Competitive Strengths & Weaknesses
Table 109. Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table 110. Sorrento Therapeutics Major Business
Table 111. Sorrento Therapeutics Autologous Cell Therapy Products Product and Services
Table 112. Sorrento Therapeutics Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Sorrento Therapeutics Recent Developments/Updates
Table 114. Sorrento Therapeutics Competitive Strengths & Weaknesses
Table 115. Mustang Bio Basic Information, Manufacturing Base and Competitors
Table 116. Mustang Bio Major Business
Table 117. Mustang Bio Autologous Cell Therapy Products Product and Services
Table 118. Mustang Bio Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Mustang Bio Recent Developments/Updates
Table 120. Mustang Bio Competitive Strengths & Weaknesses
Table 121. Cellectis Basic Information, Manufacturing Base and Competitors
Table 122. Cellectis Major Business
Table 123. Cellectis Autologous Cell Therapy Products Product and Services
Table 124. Cellectis Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Cellectis Recent Developments/Updates
Table 126. Cellectis Competitive Strengths & Weaknesses
Table 127. Allogene Therapeutics Basic Information, Manufacturing Base and Competitors
Table 128. Allogene Therapeutics Major Business
Table 129. Allogene Therapeutics Autologous Cell Therapy Products Product and Services
Table 130. Allogene Therapeutics Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Allogene Therapeutics Recent Developments/Updates
Table 132. Allogene Therapeutics Competitive Strengths & Weaknesses
Table 133. Celyad Oncology Basic Information, Manufacturing Base and Competitors
Table 134. Celyad Oncology Major Business
Table 135. Celyad Oncology Autologous Cell Therapy Products Product and Services
Table 136. Celyad Oncology Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Celyad Oncology Recent Developments/Updates
Table 138. Celyad Oncology Competitive Strengths & Weaknesses
Table 139. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 140. Bluebird Bio Major Business
Table 141. Bluebird Bio Autologous Cell Therapy Products Product and Services
Table 142. Bluebird Bio Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bluebird Bio Recent Developments/Updates
Table 144. Lonza Basic Information, Manufacturing Base and Competitors
Table 145. Lonza Major Business
Table 146. Lonza Autologous Cell Therapy Products Product and Services
Table 147. Lonza Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Autologous Cell Therapy Products Upstream (Raw Materials)
Table 149. Autologous Cell Therapy Products Typical Customers
Table 150. Autologous Cell Therapy Products Typical Distributors
List of Figure
Figure 1. Autologous Cell Therapy Products Picture
Figure 2. World Autologous Cell Therapy Products Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Autologous Cell Therapy Products Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Autologous Cell Therapy Products Production (2018-2029) & (K Units)
Figure 5. World Autologous Cell Therapy Products Average Price (2018-2029) & (US$/Unit)
Figure 6. World Autologous Cell Therapy Products Production Value Market Share by Region (2018-2029)
Figure 7. World Autologous Cell Therapy Products Production Market Share by Region (2018-2029)
Figure 8. North America Autologous Cell Therapy Products Production (2018-2029) & (K Units)
Figure 9. Europe Autologous Cell Therapy Products Production (2018-2029) & (K Units)
Figure 10. China Autologous Cell Therapy Products Production (2018-2029) & (K Units)
Figure 11. Japan Autologous Cell Therapy Products Production (2018-2029) & (K Units)
Figure 12. Autologous Cell Therapy Products Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 15. World Autologous Cell Therapy Products Consumption Market Share by Region (2018-2029)
Figure 16. United States Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 17. China Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 18. Europe Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 19. Japan Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 20. South Korea Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 22. India Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Autologous Cell Therapy Products by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Autologous Cell Therapy Products Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Autologous Cell Therapy Products Markets in 2022
Figure 26. United States VS China: Autologous Cell Therapy Products Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Autologous Cell Therapy Products Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Autologous Cell Therapy Products Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Autologous Cell Therapy Products Production Market Share 2022
Figure 30. China Based Manufacturers Autologous Cell Therapy Products Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Autologous Cell Therapy Products Production Market Share 2022
Figure 32. World Autologous Cell Therapy Products Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Autologous Cell Therapy Products Production Value Market Share by Type in 2022
Figure 34. Autologous Stem Cell Transplants
Figure 35. Autologous T Cell Therapies
Figure 36. Platelet-Rich Plasma (PRP) Therapy
Figure 37. Others
Figure 38. World Autologous Cell Therapy Products Production Market Share by Type (2018-2029)
Figure 39. World Autologous Cell Therapy Products Production Value Market Share by Type (2018-2029)
Figure 40. World Autologous Cell Therapy Products Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Autologous Cell Therapy Products Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Autologous Cell Therapy Products Production Value Market Share by Application in 2022
Figure 43. Cancer
Figure 44. Hemophilia
Figure 45. Others
Figure 46. World Autologous Cell Therapy Products Production Market Share by Application (2018-2029)
Figure 47. World Autologous Cell Therapy Products Production Value Market Share by Application (2018-2029)
Figure 48. World Autologous Cell Therapy Products Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Autologous Cell Therapy Products Industry Chain
Figure 50. Autologous Cell Therapy Products Procurement Model
Figure 51. Autologous Cell Therapy Products Sales Model
Figure 52. Autologous Cell Therapy Products Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Table 1. World Autologous Cell Therapy Products Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Autologous Cell Therapy Products Production Value by Region (2018-2023) & (USD Million)
Table 3. World Autologous Cell Therapy Products Production Value by Region (2024-2029) & (USD Million)
Table 4. World Autologous Cell Therapy Products Production Value Market Share by Region (2018-2023)
Table 5. World Autologous Cell Therapy Products Production Value Market Share by Region (2024-2029)
Table 6. World Autologous Cell Therapy Products Production by Region (2018-2023) & (K Units)
Table 7. World Autologous Cell Therapy Products Production by Region (2024-2029) & (K Units)
Table 8. World Autologous Cell Therapy Products Production Market Share by Region (2018-2023)
Table 9. World Autologous Cell Therapy Products Production Market Share by Region (2024-2029)
Table 10. World Autologous Cell Therapy Products Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Autologous Cell Therapy Products Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Autologous Cell Therapy Products Major Market Trends
Table 13. World Autologous Cell Therapy Products Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Autologous Cell Therapy Products Consumption by Region (2018-2023) & (K Units)
Table 15. World Autologous Cell Therapy Products Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Autologous Cell Therapy Products Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Autologous Cell Therapy Products Producers in 2022
Table 18. World Autologous Cell Therapy Products Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Autologous Cell Therapy Products Producers in 2022
Table 20. World Autologous Cell Therapy Products Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Autologous Cell Therapy Products Company Evaluation Quadrant
Table 22. World Autologous Cell Therapy Products Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Autologous Cell Therapy Products Production Site of Key Manufacturer
Table 24. Autologous Cell Therapy Products Market: Company Product Type Footprint
Table 25. Autologous Cell Therapy Products Market: Company Product Application Footprint
Table 26. Autologous Cell Therapy Products Competitive Factors
Table 27. Autologous Cell Therapy Products New Entrant and Capacity Expansion Plans
Table 28. Autologous Cell Therapy Products Mergers & Acquisitions Activity
Table 29. United States VS China Autologous Cell Therapy Products Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Autologous Cell Therapy Products Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Autologous Cell Therapy Products Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Autologous Cell Therapy Products Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Autologous Cell Therapy Products Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Autologous Cell Therapy Products Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Autologous Cell Therapy Products Production Market Share (2018-2023)
Table 37. China Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Autologous Cell Therapy Products Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Autologous Cell Therapy Products Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Autologous Cell Therapy Products Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Autologous Cell Therapy Products Production Market Share (2018-2023)
Table 42. Rest of World Based Autologous Cell Therapy Products Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Autologous Cell Therapy Products Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Autologous Cell Therapy Products Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Autologous Cell Therapy Products Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Autologous Cell Therapy Products Production Market Share (2018-2023)
Table 47. World Autologous Cell Therapy Products Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Autologous Cell Therapy Products Production by Type (2018-2023) & (K Units)
Table 49. World Autologous Cell Therapy Products Production by Type (2024-2029) & (K Units)
Table 50. World Autologous Cell Therapy Products Production Value by Type (2018-2023) & (USD Million)
Table 51. World Autologous Cell Therapy Products Production Value by Type (2024-2029) & (USD Million)
Table 52. World Autologous Cell Therapy Products Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Autologous Cell Therapy Products Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Autologous Cell Therapy Products Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Autologous Cell Therapy Products Production by Application (2018-2023) & (K Units)
Table 56. World Autologous Cell Therapy Products Production by Application (2024-2029) & (K Units)
Table 57. World Autologous Cell Therapy Products Production Value by Application (2018-2023) & (USD Million)
Table 58. World Autologous Cell Therapy Products Production Value by Application (2024-2029) & (USD Million)
Table 59. World Autologous Cell Therapy Products Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Autologous Cell Therapy Products Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Autologous Cell Therapy Products Product and Services
Table 64. Novartis Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 68. Gilead Sciences Major Business
Table 69. Gilead Sciences Autologous Cell Therapy Products Product and Services
Table 70. Gilead Sciences Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Gilead Sciences Recent Developments/Updates
Table 72. Gilead Sciences Competitive Strengths & Weaknesses
Table 73. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 74. Bristol-Myers Squibb Major Business
Table 75. Bristol-Myers Squibb Autologous Cell Therapy Products Product and Services
Table 76. Bristol-Myers Squibb Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bristol-Myers Squibb Recent Developments/Updates
Table 78. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 79. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 80. Johnson & Johnson Major Business
Table 81. Johnson & Johnson Autologous Cell Therapy Products Product and Services
Table 82. Johnson & Johnson Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Johnson & Johnson Recent Developments/Updates
Table 84. Johnson & Johnson Competitive Strengths & Weaknesses
Table 85. Autolus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Autolus Therapeutics Major Business
Table 87. Autolus Therapeutics Autologous Cell Therapy Products Product and Services
Table 88. Autolus Therapeutics Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Autolus Therapeutics Recent Developments/Updates
Table 90. Autolus Therapeutics Competitive Strengths & Weaknesses
Table 91. FOSUNKite Basic Information, Manufacturing Base and Competitors
Table 92. FOSUNKite Major Business
Table 93. FOSUNKite Autologous Cell Therapy Products Product and Services
Table 94. FOSUNKite Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. FOSUNKite Recent Developments/Updates
Table 96. FOSUNKite Competitive Strengths & Weaknesses
Table 97. JW Therapeutics Basic Information, Manufacturing Base and Competitors
Table 98. JW Therapeutics Major Business
Table 99. JW Therapeutics Autologous Cell Therapy Products Product and Services
Table 100. JW Therapeutics Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. JW Therapeutics Recent Developments/Updates
Table 102. JW Therapeutics Competitive Strengths & Weaknesses
Table 103. CARsgen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 104. CARsgen Therapeutics Major Business
Table 105. CARsgen Therapeutics Autologous Cell Therapy Products Product and Services
Table 106. CARsgen Therapeutics Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. CARsgen Therapeutics Recent Developments/Updates
Table 108. CARsgen Therapeutics Competitive Strengths & Weaknesses
Table 109. Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table 110. Sorrento Therapeutics Major Business
Table 111. Sorrento Therapeutics Autologous Cell Therapy Products Product and Services
Table 112. Sorrento Therapeutics Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Sorrento Therapeutics Recent Developments/Updates
Table 114. Sorrento Therapeutics Competitive Strengths & Weaknesses
Table 115. Mustang Bio Basic Information, Manufacturing Base and Competitors
Table 116. Mustang Bio Major Business
Table 117. Mustang Bio Autologous Cell Therapy Products Product and Services
Table 118. Mustang Bio Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Mustang Bio Recent Developments/Updates
Table 120. Mustang Bio Competitive Strengths & Weaknesses
Table 121. Cellectis Basic Information, Manufacturing Base and Competitors
Table 122. Cellectis Major Business
Table 123. Cellectis Autologous Cell Therapy Products Product and Services
Table 124. Cellectis Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Cellectis Recent Developments/Updates
Table 126. Cellectis Competitive Strengths & Weaknesses
Table 127. Allogene Therapeutics Basic Information, Manufacturing Base and Competitors
Table 128. Allogene Therapeutics Major Business
Table 129. Allogene Therapeutics Autologous Cell Therapy Products Product and Services
Table 130. Allogene Therapeutics Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Allogene Therapeutics Recent Developments/Updates
Table 132. Allogene Therapeutics Competitive Strengths & Weaknesses
Table 133. Celyad Oncology Basic Information, Manufacturing Base and Competitors
Table 134. Celyad Oncology Major Business
Table 135. Celyad Oncology Autologous Cell Therapy Products Product and Services
Table 136. Celyad Oncology Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Celyad Oncology Recent Developments/Updates
Table 138. Celyad Oncology Competitive Strengths & Weaknesses
Table 139. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 140. Bluebird Bio Major Business
Table 141. Bluebird Bio Autologous Cell Therapy Products Product and Services
Table 142. Bluebird Bio Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bluebird Bio Recent Developments/Updates
Table 144. Lonza Basic Information, Manufacturing Base and Competitors
Table 145. Lonza Major Business
Table 146. Lonza Autologous Cell Therapy Products Product and Services
Table 147. Lonza Autologous Cell Therapy Products Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Autologous Cell Therapy Products Upstream (Raw Materials)
Table 149. Autologous Cell Therapy Products Typical Customers
Table 150. Autologous Cell Therapy Products Typical Distributors
List of Figure
Figure 1. Autologous Cell Therapy Products Picture
Figure 2. World Autologous Cell Therapy Products Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Autologous Cell Therapy Products Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Autologous Cell Therapy Products Production (2018-2029) & (K Units)
Figure 5. World Autologous Cell Therapy Products Average Price (2018-2029) & (US$/Unit)
Figure 6. World Autologous Cell Therapy Products Production Value Market Share by Region (2018-2029)
Figure 7. World Autologous Cell Therapy Products Production Market Share by Region (2018-2029)
Figure 8. North America Autologous Cell Therapy Products Production (2018-2029) & (K Units)
Figure 9. Europe Autologous Cell Therapy Products Production (2018-2029) & (K Units)
Figure 10. China Autologous Cell Therapy Products Production (2018-2029) & (K Units)
Figure 11. Japan Autologous Cell Therapy Products Production (2018-2029) & (K Units)
Figure 12. Autologous Cell Therapy Products Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 15. World Autologous Cell Therapy Products Consumption Market Share by Region (2018-2029)
Figure 16. United States Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 17. China Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 18. Europe Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 19. Japan Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 20. South Korea Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 22. India Autologous Cell Therapy Products Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Autologous Cell Therapy Products by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Autologous Cell Therapy Products Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Autologous Cell Therapy Products Markets in 2022
Figure 26. United States VS China: Autologous Cell Therapy Products Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Autologous Cell Therapy Products Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Autologous Cell Therapy Products Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Autologous Cell Therapy Products Production Market Share 2022
Figure 30. China Based Manufacturers Autologous Cell Therapy Products Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Autologous Cell Therapy Products Production Market Share 2022
Figure 32. World Autologous Cell Therapy Products Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Autologous Cell Therapy Products Production Value Market Share by Type in 2022
Figure 34. Autologous Stem Cell Transplants
Figure 35. Autologous T Cell Therapies
Figure 36. Platelet-Rich Plasma (PRP) Therapy
Figure 37. Others
Figure 38. World Autologous Cell Therapy Products Production Market Share by Type (2018-2029)
Figure 39. World Autologous Cell Therapy Products Production Value Market Share by Type (2018-2029)
Figure 40. World Autologous Cell Therapy Products Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Autologous Cell Therapy Products Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Autologous Cell Therapy Products Production Value Market Share by Application in 2022
Figure 43. Cancer
Figure 44. Hemophilia
Figure 45. Others
Figure 46. World Autologous Cell Therapy Products Production Market Share by Application (2018-2029)
Figure 47. World Autologous Cell Therapy Products Production Value Market Share by Application (2018-2029)
Figure 48. World Autologous Cell Therapy Products Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Autologous Cell Therapy Products Industry Chain
Figure 50. Autologous Cell Therapy Products Procurement Model
Figure 51. Autologous Cell Therapy Products Sales Model
Figure 52. Autologous Cell Therapy Products Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
